Effect of Rotating Magnetic Therapy on Blood Glucose Spectrum of Type 2 Diabetic Patients With Glargine Therapy

Study Overview
=================
Brief Summary
-----------------
The aim of the study is to assess the eﬀect of Rotating Magnetic Therapy on blood glucose spectrum of type 2 diabetic patients with glargine therapy using flash glucose monitors

Official Title
-----------------
Effect of Rotating Magnetic Therapy on Blood Glucose Spectrum of Type 2 Diabetic Patients With Glargine Therapy

Conditions
-----------------
Type 2 Diabetes

Intervention / Treatment
-----------------
* Device: Rotating Magnetic Therapy


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Volunteer to participate and sign informed consent prior to the study Patients with type 2 diabetes, who met WHO1999 diagnostic criteria, aged 18-70 years old, and were treated with insulin glargine alone and/or insulin glargine combined with oral hypoglycemic drugs, the treatment regimen was stable for more than 2 months Fasting blood glucose ranged from 6.1 to 13.9mmolL, and postprandial (or random) blood glucose was <22.2mmol/L. Subjects can and are willing to conduct flash glucose monitoring and regular diet and exercise Exclusion Criteria: Patients with insulin allergy Patients treated with GLP-1a or DPP-4 inhibitors or multipoint subcutaneous insulin injection in the last three months Impaired liver and kidney function with ALT 2.5 times higher than the upper limit of normal value and serum creatinine 1.3 times higher than the upper limit of normal value Patients with metal foreign bodies or pacemakers Patients with a history of surgery in magnetic therapy site within one year Patients with obvious discomfort to magnetic therapy Patients with bleeding or bleeding tendency Patients with poor compliance and irregular diet and exercise Patients with acute complications of diabetes, such as infection, diabetic ketoacidosis, hypertonic coma and so on, and patients with stress status within four weeks Patients who are pregnant, breast-feeding, or intending to become pregnant Any other apparent conditions or associated diseases determined by the investigator: severe cardiopulmonary, endocrine, neurological, tumor, other pancreatic diseases, history of mental illness

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 70 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| No Intervention: Control<br> | |
| Experimental: Rotating Magnetic Therapy group<br> | Device: Rotating Magnetic Therapy<br>* Rotating Magnetic Therapy 30min/ Bid for 1 month<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| the standard deviation of blood glucose | the difference of the standard deviation of blood glucose between the two groups assessed by FGM | 2 weeks | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| mean blood glucose | mean blood glucose between the two groups assessed by FGM | 2 weeks | 
| time in range | time in range assessed by FGM | 2 weeks |